Short Interest in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Decreases By 64.8%

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 471,100 shares, a drop of 64.8% from the December 15th total of 1,340,000 shares. Based on an average trading volume of 22,860,000 shares, the days-to-cover ratio is presently 0.0 days.

CNS Pharmaceuticals Trading Down 7.1 %

Shares of CNSP traded down $0.01 during mid-day trading on Tuesday, reaching $0.11. The company’s stock had a trading volume of 19,335,906 shares, compared to its average volume of 63,018,766. The business has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.30. CNS Pharmaceuticals has a 1-year low of $0.10 and a 1-year high of $46.75. The stock has a market cap of $6.25 million, a P/E ratio of 0.00 and a beta of 2.52.

About CNS Pharmaceuticals

CNS Pharmaceuticals, Inc, a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme.